3-9810125-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001025930.5(TTLL3):c.119C>T(p.Pro40Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000395 in 1,469,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001025930.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL3 | NM_001387446.1 | c.-311C>T | upstream_gene_variant | ENST00000685419.1 | NP_001374375.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPC4-TTLL3 | ENST00000397256.5 | c.331-2818C>T | intron_variant | Intron 4 of 11 | 5 | ENSP00000380427.1 | ||||
TTLL3 | ENST00000685419.1 | c.-311C>T | upstream_gene_variant | NM_001387446.1 | ENSP00000510679.1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152060Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000276 AC: 2AN: 72520Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 42032
GnomAD4 exome AF: 0.0000190 AC: 25AN: 1317756Hom.: 0 Cov.: 71 AF XY: 0.0000170 AC XY: 11AN XY: 648926
GnomAD4 genome AF: 0.000217 AC: 33AN: 152060Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.119C>T (p.P40L) alteration is located in exon 1 (coding exon 1) of the TTLL3 gene. This alteration results from a C to T substitution at nucleotide position 119, causing the proline (P) at amino acid position 40 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at